Follow the ImmuneOnco Biopharmaceuticals (Shanghai) Inc. - B - H Shares share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Market capitalisation: €151.2m. The latest transaction was disclosed on 20 May 2026 (Other). Among the most active insiders: Tian Wenzhi. The full history is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos inmunológicos para el cáncer. Cotiza en la categoría de Acciones H.